Investor Relations
We have developed a strong portfolio of patented technologies and products for enhancing the health and well-being of humans and animals. Our unique and innovative antimicrobial membrane technologies used in our air filtration products, surgical masks and respirators differentiate us from our competitors in a rapidly growing global market. We are also expanding our line of high quality, cutting-edge, portable animal ultrasound scanners for use in human medicine.
We are committed to becoming a market leader by enhancing our existing technologies and products, designing innovative new applications, licensing production of our antimicrobial products and hand sanitizers to independent partners; and, by expanding our proprietary and partner distributor networks globally.
Recent Press Releases
Noveko | TSX:EKO
| C$ | 1.42 |
| Daily High/Low | 1.46 / 1.41 |
| 52 Week High/Low | 3.35 / 0.55 |
| Market Cap | 107800720 |
| Shares Outstanding | 75916000 |
Quotes delayed at least 20 mins.
Contact Information
Investor Relations
Chantal Vennat
500, Place d'Armes, Suite 1600
Montreal (Quebec)
H2Y 2W2, Canada
Telephone: 514.875.0606
Fax: 514.875.0660
cvennat@noveko.com
Transfer Agent
Computershare Trust Company of Canada
1500 University Street, Suite 700
Montreal (Quebec)
H3A 3S8, Canada
Telephone: 514.982.7555
Toll Free: 1.800.564.6253
General Inquires
Click here to contact us